DKM Wealth Management’s Pacific Biosciences PACB Stock Holding History

DKM Wealth Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$23.7K	Hold	10,000	–	–	0.02%	70
2026 Q2	$16.8K	Hold	10,000	–	–	0.01%	69
2026 Q1	$13.2K	Hold	10,000	–	–	0.01%	75
2025 Q4	$18.7K	Buy	+10,000	New	+$19.2K	0.01%	72

Other funds holding PACB

MCP

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

GAA

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

VVP

Venture Visionary Partners Sylvania, Ohio $3.82B AUM 21.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

DKM Wealth Management's PACB Position: Q3 2026 in Review

DKM Wealth Management held its Pacific Biosciences (PACB) position steady in Q3 2026 at 10,000 shares worth $23.7K. The position accounts for 0.02% of the portfolio, ranked #70.

DKM Wealth Management first reported a position in PACB in Q4 2025 and has held it in 4 quarters since. 6 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

DKM Wealth Management held 10,000 shares of Pacific Biosciences worth $23.7K as of Q3 2026.
DKM Wealth Management left its Pacific Biosciences share count unchanged in Q3 2026.
Pacific Biosciences made up 0.02% of DKM Wealth Management's portfolio in Q3 2026, its #70 holding.
DKM Wealth Management first reported a position in Pacific Biosciences in Q4 2025 and has held it in 4 quarters since.
6 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on DKM Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.